Triglyceride glucose index, a marker of insulin resistance, is associated with coronary artery stenosis in asymptomatic subjects with type 2 diabetes
Background Insulin resistance is one of the most important contributing factors to cardiovascular disease. This study aimed to investigate the association between coronary artery stenosis (CAS) and triglyceride glucose index (TyG index), a simple insulin resistance marker, in asymptomatic subjects w...
Saved in:
| Published in | Lipids in health and disease Vol. 15; no. 1; p. 155 |
|---|---|
| Main Authors | , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
BioMed Central
15.09.2016
BioMed Central Ltd |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1476-511X 1476-511X |
| DOI | 10.1186/s12944-016-0324-2 |
Cover
| Abstract | Background
Insulin resistance is one of the most important contributing factors to cardiovascular disease. This study aimed to investigate the association between coronary artery stenosis (CAS) and triglyceride glucose index (TyG index), a simple insulin resistance marker, in asymptomatic subjects with type 2 diabetes.
Methods
We recruited asymptomatic adults with type 2 diabetes but without previous history of coronary heart disease (
n
= 888). Significant CAS was defined as maximum intraluminal stenosis ≥70 % by coronary CT angiography. TyG index was calculated as log [fasting triglycerides (mg/dl) x fasting glucose (mg/dl)/2].
Results
Mean age was 63.8 ± 9.5 and 58.9 % of the subjects were men. We analyzed the participants according to the tertile of TyG index. The TyG index was correlated with HOMA-IR (
r
= 0.397,
P
< 0.001), and subjects with higher tertile of TyG index were younger but showed worse clinical and metabolic parameters. The prevalence of CAS was higher in subjects with higher tertile of TyG compared with those with lower tertile of TyG (14 % vs. 7.8 %,
P
= 0.022). On multiple regression analysis, the highest tertile of TyG index was an independent risk factor for CAS after adjustment for other confounders (odds ratio, 3.19 [95 % CI, 1.371–7.424]). Subgroup analysis showed that TyG index showed more significant association with CAS in patients with risk factors such as old age, longer duration of diabetes, poor glycemic control, no statin use, and male gender.
Conclusion
Higher TyG index is associated with increased risk of CAS in asymptomatic subjects with type 2 diabetes, particularly when they have risk factors for cardiovascular disease.
Trial registration
This study was retrospectively registered in ClinicalTrials. gov with the registration number of
NCT02070926
in Feb 23, 2014. |
|---|---|
| AbstractList | Insulin resistance is one of the most important contributing factors to cardiovascular disease. This study aimed to investigate the association between coronary artery stenosis (CAS) and triglyceride glucose index (TyG index), a simple insulin resistance marker, in asymptomatic subjects with type 2 diabetes.BACKGROUNDInsulin resistance is one of the most important contributing factors to cardiovascular disease. This study aimed to investigate the association between coronary artery stenosis (CAS) and triglyceride glucose index (TyG index), a simple insulin resistance marker, in asymptomatic subjects with type 2 diabetes.We recruited asymptomatic adults with type 2 diabetes but without previous history of coronary heart disease (n = 888). Significant CAS was defined as maximum intraluminal stenosis ≥70 % by coronary CT angiography. TyG index was calculated as log [fasting triglycerides (mg/dl) x fasting glucose (mg/dl)/2].METHODSWe recruited asymptomatic adults with type 2 diabetes but without previous history of coronary heart disease (n = 888). Significant CAS was defined as maximum intraluminal stenosis ≥70 % by coronary CT angiography. TyG index was calculated as log [fasting triglycerides (mg/dl) x fasting glucose (mg/dl)/2].Mean age was 63.8 ± 9.5 and 58.9 % of the subjects were men. We analyzed the participants according to the tertile of TyG index. The TyG index was correlated with HOMA-IR (r = 0.397, P < 0.001), and subjects with higher tertile of TyG index were younger but showed worse clinical and metabolic parameters. The prevalence of CAS was higher in subjects with higher tertile of TyG compared with those with lower tertile of TyG (14 % vs. 7.8 %, P = 0.022). On multiple regression analysis, the highest tertile of TyG index was an independent risk factor for CAS after adjustment for other confounders (odds ratio, 3.19 [95 % CI, 1.371-7.424]). Subgroup analysis showed that TyG index showed more significant association with CAS in patients with risk factors such as old age, longer duration of diabetes, poor glycemic control, no statin use, and male gender.RESULTSMean age was 63.8 ± 9.5 and 58.9 % of the subjects were men. We analyzed the participants according to the tertile of TyG index. The TyG index was correlated with HOMA-IR (r = 0.397, P < 0.001), and subjects with higher tertile of TyG index were younger but showed worse clinical and metabolic parameters. The prevalence of CAS was higher in subjects with higher tertile of TyG compared with those with lower tertile of TyG (14 % vs. 7.8 %, P = 0.022). On multiple regression analysis, the highest tertile of TyG index was an independent risk factor for CAS after adjustment for other confounders (odds ratio, 3.19 [95 % CI, 1.371-7.424]). Subgroup analysis showed that TyG index showed more significant association with CAS in patients with risk factors such as old age, longer duration of diabetes, poor glycemic control, no statin use, and male gender.Higher TyG index is associated with increased risk of CAS in asymptomatic subjects with type 2 diabetes, particularly when they have risk factors for cardiovascular disease.CONCLUSIONHigher TyG index is associated with increased risk of CAS in asymptomatic subjects with type 2 diabetes, particularly when they have risk factors for cardiovascular disease.This study was retrospectively registered in ClinicalTrials. gov with the registration number of NCT02070926 in Feb 23, 2014.TRIAL REGISTRATIONThis study was retrospectively registered in ClinicalTrials. gov with the registration number of NCT02070926 in Feb 23, 2014. Background Insulin resistance is one of the most important contributing factors to cardiovascular disease. This study aimed to investigate the association between coronary artery stenosis (CAS) and triglyceride glucose index (TyG index), a simple insulin resistance marker, in asymptomatic subjects with type 2 diabetes. Methods We recruited asymptomatic adults with type 2 diabetes but without previous history of coronary heart disease ( n = 888). Significant CAS was defined as maximum intraluminal stenosis ≥70 % by coronary CT angiography. TyG index was calculated as log [fasting triglycerides (mg/dl) x fasting glucose (mg/dl)/2]. Results Mean age was 63.8 ± 9.5 and 58.9 % of the subjects were men. We analyzed the participants according to the tertile of TyG index. The TyG index was correlated with HOMA-IR ( r = 0.397, P < 0.001), and subjects with higher tertile of TyG index were younger but showed worse clinical and metabolic parameters. The prevalence of CAS was higher in subjects with higher tertile of TyG compared with those with lower tertile of TyG (14 % vs. 7.8 %, P = 0.022). On multiple regression analysis, the highest tertile of TyG index was an independent risk factor for CAS after adjustment for other confounders (odds ratio, 3.19 [95 % CI, 1.371–7.424]). Subgroup analysis showed that TyG index showed more significant association with CAS in patients with risk factors such as old age, longer duration of diabetes, poor glycemic control, no statin use, and male gender. Conclusion Higher TyG index is associated with increased risk of CAS in asymptomatic subjects with type 2 diabetes, particularly when they have risk factors for cardiovascular disease. Trial registration This study was retrospectively registered in ClinicalTrials. gov with the registration number of NCT02070926 in Feb 23, 2014. Insulin resistance is one of the most important contributing factors to cardiovascular disease. This study aimed to investigate the association between coronary artery stenosis (CAS) and triglyceride glucose index (TyG index), a simple insulin resistance marker, in asymptomatic subjects with type 2 diabetes. We recruited asymptomatic adults with type 2 diabetes but without previous history of coronary heart disease (n = 888). Significant CAS was defined as maximum intraluminal stenosis ≥70 % by coronary CT angiography. TyG index was calculated as log [fasting triglycerides (mg/dl) x fasting glucose (mg/dl)/2]. Mean age was 63.8 ± 9.5 and 58.9 % of the subjects were men. We analyzed the participants according to the tertile of TyG index. The TyG index was correlated with HOMA-IR (r = 0.397, P < 0.001), and subjects with higher tertile of TyG index were younger but showed worse clinical and metabolic parameters. The prevalence of CAS was higher in subjects with higher tertile of TyG compared with those with lower tertile of TyG (14 % vs. 7.8 %, P = 0.022). On multiple regression analysis, the highest tertile of TyG index was an independent risk factor for CAS after adjustment for other confounders (odds ratio, 3.19 [95 % CI, 1.371-7.424]). Subgroup analysis showed that TyG index showed more significant association with CAS in patients with risk factors such as old age, longer duration of diabetes, poor glycemic control, no statin use, and male gender. Higher TyG index is associated with increased risk of CAS in asymptomatic subjects with type 2 diabetes, particularly when they have risk factors for cardiovascular disease. This study was retrospectively registered in ClinicalTrials. gov with the registration number of NCT02070926 in Feb 23, 2014. Background Insulin resistance is one of the most important contributing factors to cardiovascular disease. This study aimed to investigate the association between coronary artery stenosis (CAS) and triglyceride glucose index (TyG index), a simple insulin resistance marker, in asymptomatic subjects with type 2 diabetes. Methods We recruited asymptomatic adults with type 2 diabetes but without previous history of coronary heart disease (n = 888). Significant CAS was defined as maximum intraluminal stenosis ≥70 % by coronary CT angiography. TyG index was calculated as log [fasting triglycerides (mg/dl) x fasting glucose (mg/dl)/2]. Results Mean age was 63.8 ± 9.5 and 58.9 % of the subjects were men. We analyzed the participants according to the tertile of TyG index. The TyG index was correlated with HOMA-IR (r = 0.397, P < 0.001), and subjects with higher tertile of TyG index were younger but showed worse clinical and metabolic parameters. The prevalence of CAS was higher in subjects with higher tertile of TyG compared with those with lower tertile of TyG (14 % vs. 7.8 %, P = 0.022). On multiple regression analysis, the highest tertile of TyG index was an independent risk factor for CAS after adjustment for other confounders (odds ratio, 3.19 [95 % CI, 1.371-7.424]). Subgroup analysis showed that TyG index showed more significant association with CAS in patients with risk factors such as old age, longer duration of diabetes, poor glycemic control, no statin use, and male gender. Conclusion Higher TyG index is associated with increased risk of CAS in asymptomatic subjects with type 2 diabetes, particularly when they have risk factors for cardiovascular disease. Background Insulin resistance is one of the most important contributing factors to cardiovascular disease. This study aimed to investigate the association between coronary artery stenosis (CAS) and triglyceride glucose index (TyG index), a simple insulin resistance marker, in asymptomatic subjects with type 2 diabetes. Methods We recruited asymptomatic adults with type 2 diabetes but without previous history of coronary heart disease (n = 888). Significant CAS was defined as maximum intraluminal stenosis [greater than or equai to]70 % by coronary CT angiography. TyG index was calculated as log [fasting triglycerides (mg/dl) x fasting glucose (mg/dl)/2]. Results Mean age was 63.8 [+ or -] 9.5 and 58.9 % of the subjects were men. We analyzed the participants according to the tertile of TyG index. The TyG index was correlated with HOMA-IR (r = 0.397, P < 0.001), and subjects with higher tertile of TyG index were younger but showed worse clinical and metabolic parameters. The prevalence of CAS was higher in subjects with higher tertile of TyG compared with those with lower tertile of TyG (14 % vs. 7.8 %, P = 0.022). On multiple regression analysis, the highest tertile of TyG index was an independent risk factor for CAS after adjustment for other confounders (odds ratio, 3.19 [95 % CI, 1.371-7.424]). Subgroup analysis showed that TyG index showed more significant association with CAS in patients with risk factors such as old age, longer duration of diabetes, poor glycemic control, no statin use, and male gender. Conclusion Higher TyG index is associated with increased risk of CAS in asymptomatic subjects with type 2 diabetes, particularly when they have risk factors for cardiovascular disease. Trial registration This study was retrospectively registered in ClinicalTrials. gov with the registration number of NCT02070926 in Feb 23, 2014. Keywords: Atherosclerosis, Coronary, TyG index, Type 2 diabetes Insulin resistance is one of the most important contributing factors to cardiovascular disease. This study aimed to investigate the association between coronary artery stenosis (CAS) and triglyceride glucose index (TyG index), a simple insulin resistance marker, in asymptomatic subjects with type 2 diabetes. We recruited asymptomatic adults with type 2 diabetes but without previous history of coronary heart disease (n = 888). Significant CAS was defined as maximum intraluminal stenosis [greater than or equai to]70 % by coronary CT angiography. TyG index was calculated as log [fasting triglycerides (mg/dl) x fasting glucose (mg/dl)/2]. Mean age was 63.8 [+ or -] 9.5 and 58.9 % of the subjects were men. We analyzed the participants according to the tertile of TyG index. The TyG index was correlated with HOMA-IR (r = 0.397, P < 0.001), and subjects with higher tertile of TyG index were younger but showed worse clinical and metabolic parameters. The prevalence of CAS was higher in subjects with higher tertile of TyG compared with those with lower tertile of TyG (14 % vs. 7.8 %, P = 0.022). On multiple regression analysis, the highest tertile of TyG index was an independent risk factor for CAS after adjustment for other confounders (odds ratio, 3.19 [95 % CI, 1.371-7.424]). Subgroup analysis showed that TyG index showed more significant association with CAS in patients with risk factors such as old age, longer duration of diabetes, poor glycemic control, no statin use, and male gender. Higher TyG index is associated with increased risk of CAS in asymptomatic subjects with type 2 diabetes, particularly when they have risk factors for cardiovascular disease. |
| ArticleNumber | 155 |
| Audience | Academic |
| Author | Lee, Joonyub Cha, Bong Yun Cho, Jae Hyoung Lee, Seung-Hwan Yang, Hae Kyung Yang, Yeoree Lee, Eun Young Yoon, Kun-Ho Kang, Borami Ko, Seung-Hyun Ahn, Yu-Bae |
| Author_xml | – sequence: 1 givenname: Eun Young surname: Lee fullname: Lee, Eun Young organization: Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea – sequence: 2 givenname: Hae Kyung surname: Yang fullname: Yang, Hae Kyung organization: Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea – sequence: 3 givenname: Joonyub surname: Lee fullname: Lee, Joonyub organization: Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea – sequence: 4 givenname: Borami surname: Kang fullname: Kang, Borami organization: Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea – sequence: 5 givenname: Yeoree surname: Yang fullname: Yang, Yeoree organization: Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea – sequence: 6 givenname: Seung-Hwan surname: Lee fullname: Lee, Seung-Hwan organization: Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea – sequence: 7 givenname: Seung-Hyun surname: Ko fullname: Ko, Seung-Hyun organization: Division of Endocrinology and Metabolism, Department of Internal Medicine, St. Vincent’s Hospital, College of Medicine, The Catholic University of Korea – sequence: 8 givenname: Yu-Bae surname: Ahn fullname: Ahn, Yu-Bae organization: Division of Endocrinology and Metabolism, Department of Internal Medicine, St. Vincent’s Hospital, College of Medicine, The Catholic University of Korea – sequence: 9 givenname: Bong Yun surname: Cha fullname: Cha, Bong Yun organization: Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea – sequence: 10 givenname: Kun-Ho surname: Yoon fullname: Yoon, Kun-Ho organization: Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Institute of Catholic Ubiquitous Health Care, The Catholic University of Korea – sequence: 11 givenname: Jae Hyoung surname: Cho fullname: Cho, Jae Hyoung email: drhoppoer@catholic.ac.kr organization: Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Institute of Catholic Ubiquitous Health Care, The Catholic University of Korea |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27633375$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9ks1u1DAUhSNURH_gAdggS2xYNMV27CSzQaoq_qRKbIrEznLsm6mHxB58ncI8CO-Lo7QwrQBFiq2b7xzrxOe4OPDBQ1E8Z_SMsbZ-jYyvhCgpq0tacVHyR8URE01dSsa-HOztD4tjxA2lnDZ1_aQ45E1dVVUjj4qfV9Gth52B6CyQ9TCZgECct_DjlGgy6vgVIgl9HuE0OE8ioMOkvYFT4pBoxGCcTmDJd5euiQkxeB13RMcEecEEPmRF1md2N25TGHVyhuDUbcAkXGRptwXCiXW6gwT4tHjc6wHh2e16Unx-9_bq4kN5-en9x4vzy9LIqkllo8Wqbu0cBdr8tpJVYKqukz2TQreS8a7tO1NRLeuOcStXrex7KqzteAuiOineLL7bqRvBGvAp6kFto8vBdypop-5_8e5arcONkpQL0TTZ4NWtQQzfJsCkRocGhkF7CBMq1nJa5_tpeEZfPkA3YYo-x5upDDG2av9Qaz2Acr4P-Vwzm6pzUQtBabWSmTr7C5UfC6MzuSS9y_N7ghf7QX8nvCtCBpoFMDEgRuiVcSlfVJhzu0ExqubKqaVyKkdSc-XUnIs9UN6Z_0_DFw1m1q8h7v2Lf4p-AQ6g6ho |
| CitedBy_id | crossref_primary_10_1186_s12933_024_02290_3 crossref_primary_10_1186_s12933_022_01511_x crossref_primary_10_3390_nu12020328 crossref_primary_10_4103_bjem_bjem_4_23 crossref_primary_10_1186_s12933_023_01762_2 crossref_primary_10_3389_fcimb_2023_1196338 crossref_primary_10_1186_s12933_020_01008_5 crossref_primary_10_12677_ACM_2023_1371648 crossref_primary_10_1186_s12933_023_02054_5 crossref_primary_10_1016_j_numecd_2021_06_019 crossref_primary_10_1016_j_numecd_2020_07_041 crossref_primary_10_1186_s12872_023_03294_9 crossref_primary_10_1186_s13098_023_01153_3 crossref_primary_10_12677_acm_2024_143908 crossref_primary_10_7759_cureus_75841 crossref_primary_10_1159_000500979 crossref_primary_10_2298_MPNS2208237S crossref_primary_10_3389_fendo_2024_1458521 crossref_primary_10_3389_fneur_2023_1198487 crossref_primary_10_1186_s12944_018_0914_2 crossref_primary_10_7759_cureus_68235 crossref_primary_10_1186_s12933_023_01895_4 crossref_primary_10_23736_S0022_4707_20_11105_8 crossref_primary_10_3389_fcvm_2023_1086978 crossref_primary_10_1186_s12933_022_01470_3 crossref_primary_10_1186_s12933_020_01031_6 crossref_primary_10_3389_fcvm_2022_832491 crossref_primary_10_1186_s12933_019_0957_3 crossref_primary_10_1186_s12933_019_0893_2 crossref_primary_10_4103_MJBL_MJBL_269_22 crossref_primary_10_3889_oamjms_2021_7075 crossref_primary_10_1186_s13098_023_01181_z crossref_primary_10_1186_s12933_023_01780_0 crossref_primary_10_1016_j_numecd_2023_12_025 crossref_primary_10_1186_s12933_024_02209_y crossref_primary_10_1186_s12933_021_01238_1 crossref_primary_10_2217_bmm_2024_0015 crossref_primary_10_1097_XCE_0000000000000277 crossref_primary_10_1016_j_dsx_2021_102280 crossref_primary_10_1186_s12933_020_01210_5 crossref_primary_10_1016_j_pmedr_2022_101941 crossref_primary_10_1016_j_exger_2021_111389 crossref_primary_10_1186_s12933_023_02013_0 crossref_primary_10_1186_s12933_019_0898_x crossref_primary_10_3389_fendo_2024_1414402 crossref_primary_10_12677_ACM_2022_12111445 crossref_primary_10_1186_s12933_017_0589_4 crossref_primary_10_3389_fpubh_2023_1028461 crossref_primary_10_1371_journal_pone_0212963 crossref_primary_10_1186_s12933_020_01108_2 crossref_primary_10_1016_j_clnu_2017_06_018 crossref_primary_10_1371_journal_pone_0312374 crossref_primary_10_1186_s12944_025_02449_1 crossref_primary_10_1080_00015385_2024_2413737 crossref_primary_10_1186_s12933_021_01268_9 crossref_primary_10_1016_j_jacl_2024_09_011 crossref_primary_10_1016_j_numecd_2021_04_010 crossref_primary_10_1186_s12933_023_01739_1 crossref_primary_10_1186_s12933_022_01620_7 crossref_primary_10_1186_s12933_023_02082_1 crossref_primary_10_3389_fendo_2024_1416634 crossref_primary_10_1186_s12933_022_01638_x crossref_primary_10_33631_duzcesbed_882401 crossref_primary_10_1186_s12933_023_01866_9 crossref_primary_10_1007_s12011_023_03919_2 crossref_primary_10_3389_fcvm_2021_774781 crossref_primary_10_1186_s12933_021_01321_7 crossref_primary_10_2337_dc18_1920 crossref_primary_10_1016_j_dsx_2022_102581 crossref_primary_10_5604_01_3001_0054_6748 crossref_primary_10_5551_jat_59840 crossref_primary_10_1186_s12933_020_01086_5 crossref_primary_10_1080_0886022X_2024_2320261 crossref_primary_10_3389_fendo_2021_732726 crossref_primary_10_1186_s12933_020_01006_7 crossref_primary_10_1186_s12933_023_01919_z crossref_primary_10_23838_pfm_2017_00059 crossref_primary_10_1097_MS9_0000000000003019 crossref_primary_10_1186_s12933_023_01792_w crossref_primary_10_1186_s12933_022_01606_5 crossref_primary_10_12677_jcpm_2025_42144 crossref_primary_10_1007_s12020_021_02815_w crossref_primary_10_3389_fendo_2023_1201110 crossref_primary_10_1007_s13410_024_01315_7 crossref_primary_10_1177_00033197211007719 crossref_primary_10_3389_fendo_2021_710240 crossref_primary_10_3390_nu11112654 crossref_primary_10_5551_jat_61119 crossref_primary_10_1097_MPA_0000000000001809 crossref_primary_10_3389_fneur_2019_00947 crossref_primary_10_3389_fcvm_2023_1139842 crossref_primary_10_1186_s12933_023_01906_4 crossref_primary_10_1186_s40001_024_02121_x crossref_primary_10_3389_fendo_2024_1327903 crossref_primary_10_1097_MD_0000000000018265 crossref_primary_10_1111_jdi_13371 crossref_primary_10_3389_fendo_2025_1447053 crossref_primary_10_1536_ihj_23_409 crossref_primary_10_12677_ACM_2022_124365 crossref_primary_10_1186_s12902_019_0384_1 crossref_primary_10_1038_s41598_024_76530_7 crossref_primary_10_12677_acm_2024_1482349 crossref_primary_10_1097_MD_0000000000025025 crossref_primary_10_17826_cumj_1492273 crossref_primary_10_1186_s12883_021_02443_x crossref_primary_10_1186_s12933_024_02165_7 crossref_primary_10_1186_s12944_021_01532_7 crossref_primary_10_2147_VHRM_S443742 crossref_primary_10_3390_jpm11020128 crossref_primary_10_1186_s12933_021_01383_7 crossref_primary_10_1155_2019_6891537 crossref_primary_10_3389_fendo_2023_1294909 crossref_primary_10_1186_s12933_021_01236_3 crossref_primary_10_1007_s10792_024_03344_x crossref_primary_10_1186_s12933_022_01615_4 crossref_primary_10_4274_meandros_galenos_2021_27132 crossref_primary_10_3389_fendo_2022_858209 crossref_primary_10_1186_s12933_018_0692_1 crossref_primary_10_2147_DMSO_S343374 crossref_primary_10_1186_s12933_020_01186_2 crossref_primary_10_3389_fendo_2022_843072 crossref_primary_10_1097_MD_0000000000017995 crossref_primary_10_1097_HPC_0000000000000348 crossref_primary_10_1186_s12933_020_01054_z crossref_primary_10_1186_s12944_022_01738_3 crossref_primary_10_1080_13813455_2019_1680698 crossref_primary_10_3389_fneur_2020_00456 crossref_primary_10_4274_kvbulten_galenos_2024_07379 crossref_primary_10_1002_clc_23405 |
| Cites_doi | 10.1016/j.jacc.2007.01.088 10.2337/diacare.20.4.627 10.1016/j.metabol.2011.04.006 10.2337/db09-9028 10.2337/dc08-1013 10.1016/j.diabres.2011.05.030 10.1016/j.ijcard.2005.06.056 10.1089/met.2008.0034 10.1161/CIRCULATIONAHA.105.169404 10.1016/S0140-6736(97)90021-0 10.1016/j.jcct.2009.01.001 10.2337/diacare.25.7.1177 10.2337/diacare.25.7.1135 10.1016/j.jff.2013.12.006 10.1007/s001250050581 10.1111/ijcp.12124 10.2337/dc06-0919 10.4093/dmj.2015.39.5.353 10.1007/BF00280883 10.1177/14746514020020011301 10.1016/j.jcmg.2010.10.011 10.1210/edrv.23.2.0461 10.1194/jlr.R800053-JLR200 10.1210/jc.2010-0288 10.1055/s-2001-15114 10.1038/nutd.2014.46 10.2337/diacare.24.5.933 10.1007/PL00002934 |
| ContentType | Journal Article |
| Copyright | The Author(s). 2016 COPYRIGHT 2016 BioMed Central Ltd. Copyright BioMed Central 2016 |
| Copyright_xml | – notice: The Author(s). 2016 – notice: COPYRIGHT 2016 BioMed Central Ltd. – notice: Copyright BioMed Central 2016 |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FD 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M7P P64 PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS RC3 7X8 5PM |
| DOI | 10.1186/s12944-016-0324-2 |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One ProQuest Central Korea Engineering Research Database Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database Biological Science Database Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic (New) ProQuest Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Genetics Abstracts Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals (WRLC) url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Anatomy & Physiology |
| EISSN | 1476-511X |
| ExternalDocumentID | PMC5024477 4204432021 A464400395 27633375 10_1186_s12944_016_0324_2 |
| Genre | Clinical Trial Journal Article |
| GroupedDBID | --- 0R~ 29L 2WC 4.4 53G 5GY 5VS 7X7 88E 8FE 8FH 8FI 8FJ A8Z AAFWJ AAHBH AAJSJ AASML ABDBF ABUWG ACGFO ACGFS ACPRK ACUHS ADBBV ADRAZ ADUKV AENEX AFKRA AFPKN AHBYD AHMBA AHSBF AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BBNVY BCNDV BENPR BFQNJ BHPHI BMC BPHCQ BVXVI C6C CCPQU CS3 DIK E3Z EAD EAP EAS EBD EBLON EBS EJD EMB EMK EMOBN ESTFP ESX F5P FYUFA GROUPED_DOAJ GX1 H13 HCIFZ HH5 HMCUK HYE IAO IGS IHR INH INR ITC KQ8 LK8 M1P M48 M7P M~E O5R O5S OK1 OVT P2P P6G PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SBL SOJ SV3 TR2 TUS U2A UKHRP W2D WOQ WOW XSB AAYXX ALIPV CITATION CGR CUY CVF ECM EIF NPM PMFND 3V. 7XB 8FD 8FK AZQEC DWQXO FR3 GNUQQ K9. P64 PKEHL PQEST PQUKI PRINS RC3 7X8 5PM |
| ID | FETCH-LOGICAL-c537t-7a4968d3337e8333d513ec3bb5f154a8512b8fbc30a56b12d5985ff04ddb28e43 |
| IEDL.DBID | M48 |
| ISSN | 1476-511X |
| IngestDate | Thu Aug 21 18:45:24 EDT 2025 Mon Sep 08 14:59:53 EDT 2025 Fri Jul 25 19:21:06 EDT 2025 Tue Jun 17 22:04:52 EDT 2025 Tue Jun 10 21:07:04 EDT 2025 Thu Apr 03 07:08:56 EDT 2025 Thu Apr 24 22:59:46 EDT 2025 Tue Jul 01 00:23:07 EDT 2025 Sat Sep 06 07:34:25 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Type 2 diabetes Coronary Atherosclerosis TyG index |
| Language | English |
| License | Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c537t-7a4968d3337e8333d513ec3bb5f154a8512b8fbc30a56b12d5985ff04ddb28e43 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 |
| OpenAccessLink | https://www.proquest.com/docview/1826011198?pq-origsite=%requestingapplication% |
| PMID | 27633375 |
| PQID | 1826011198 |
| PQPubID | 42587 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_5024477 proquest_miscellaneous_1820601672 proquest_journals_1826011198 gale_infotracmisc_A464400395 gale_infotracacademiconefile_A464400395 pubmed_primary_27633375 crossref_citationtrail_10_1186_s12944_016_0324_2 crossref_primary_10_1186_s12944_016_0324_2 springer_journals_10_1186_s12944_016_0324_2 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2016-09-15 |
| PublicationDateYYYYMMDD | 2016-09-15 |
| PublicationDate_xml | – month: 09 year: 2016 text: 2016-09-15 day: 15 |
| PublicationDecade | 2010 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | Lipids in health and disease |
| PublicationTitleAbbrev | Lipids Health Dis |
| PublicationTitleAlternate | Lipids Health Dis |
| PublicationYear | 2016 |
| Publisher | BioMed Central BioMed Central Ltd |
| Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd |
| References | GF Lewis (324_CR23) 2002; 23 LE Simental-Mendía (324_CR9) 2008; 6 P Scicchitano (324_CR28) 2014; 6 C Irace (324_CR22) 2013; 67 GL Raff (324_CR12) 2009; 3 F Guerrero-Romero (324_CR18) 2010; 95 RA DeFronzo (324_CR14) 2009; 58 DM Nathan (324_CR3) 1997; 350 CB Giorda (324_CR2) 2008; 31 Association KD (324_CR4) 2015 KG Parhofer (324_CR24) 2015; 39 ACJ Vasques (324_CR20) 2011; 93 P Bressler (324_CR6) 1996; 39 A Onat (324_CR29) 2006; 108 E Bonora (324_CR17) 2007; 30 AJ Hanley (324_CR7) 2002; 25 E Kraegen (324_CR27) 2000; 109 S Grundy (324_CR11) 2005; 112 J Jeppesen (324_CR16) 2007; 49 CA Nagle (324_CR26) 2009; 50 S Lee (324_CR21) 2015; 5 E Bonora (324_CR8) 1997; 20 N Morrish (324_CR1) 2001; 44 E Bonora (324_CR5) 2002; 25 F Abbasi (324_CR19) 2011; 60 A Arbab-Zadeh (324_CR13) 2011; 4 JD Mills (324_CR15) 2002; 2 DE Kelley (324_CR25) 2001; 24 D Matthews (324_CR10) 1985; 28 17259501 - Diabetes Care. 2007 Feb;30(2):318-24 21329905 - JACC Cardiovasc Imaging. 2011 Feb;4(2):191-202 25915739 - Nutr Diabetes. 2015 Apr 27;5:e149 11943743 - Endocr Rev. 2002 Apr;23(2):201-29 9250276 - Lancet. 1997 Jul;350 Suppl 1:SI4-9 9096992 - Diabetes Care. 1997 Apr;20(4):627-31 23758445 - Int J Clin Pract. 2013 Jul;67(7):665-72 12087010 - Diabetes Care. 2002 Jul;25(7):1135-41 12087016 - Diabetes Care. 2002 Jul;25(7):1177-84 8933003 - Diabetologia. 1996 Nov;39(11):1345-50 18782902 - Diabetes Care. 2008 Nov;31(11):2154-9 21665314 - Diabetes Res Clin Pract. 2011 Sep;93(3):e98-e100 19336687 - Diabetes. 2009 Apr;58(4):773-95 3899825 - Diabetologia. 1985 Jul;28(7):412-9 18997164 - J Lipid Res. 2009 Apr;50 Suppl:S74-9 21632070 - Metabolism. 2011 Dec;60(12):1673-6 11453039 - Exp Clin Endocrinol Diabetes. 2001;109(4):S516-26 11347757 - Diabetes Care. 2001 May;24(5):933-41 19272853 - J Cardiovasc Comput Tomogr. 2009 Mar-Apr;3(2):122-36 26566492 - Diabetes Metab J. 2015 Oct;39(5):353-62 16085325 - Int J Cardiol. 2006 Mar 22;108(1):89-95 11587045 - Diabetologia. 2001 Sep;44 Suppl 2:S14-21 17531661 - J Am Coll Cardiol. 2007 May 29;49(21):2112-9 20484475 - J Clin Endocrinol Metab. 2010 Jul;95(7):3347-51 19067533 - Metab Syndr Relat Disord. 2008 Dec;6(4):299-304 16157765 - Circulation. 2005 Oct 25;112(17):2735-52 |
| References_xml | – volume: 49 start-page: 2112 issue: 21 year: 2007 ident: 324_CR16 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2007.01.088 – volume: 20 start-page: 627 issue: 4 year: 1997 ident: 324_CR8 publication-title: Diabetes Care doi: 10.2337/diacare.20.4.627 – volume: 60 start-page: 1673 issue: 12 year: 2011 ident: 324_CR19 publication-title: Metabolism doi: 10.1016/j.metabol.2011.04.006 – volume: 58 start-page: 773 issue: 4 year: 2009 ident: 324_CR14 publication-title: Diabetes doi: 10.2337/db09-9028 – volume: 31 start-page: 2154 issue: 11 year: 2008 ident: 324_CR2 publication-title: Diabetes Care doi: 10.2337/dc08-1013 – volume: 93 start-page: e98 issue: 3 year: 2011 ident: 324_CR20 publication-title: Diabetes Res Clin Pract doi: 10.1016/j.diabres.2011.05.030 – volume: 108 start-page: 89 issue: 1 year: 2006 ident: 324_CR29 publication-title: Int J Cardiol doi: 10.1016/j.ijcard.2005.06.056 – volume: 6 start-page: 299 issue: 4 year: 2008 ident: 324_CR9 publication-title: Metab Syndr Relat Disord doi: 10.1089/met.2008.0034 – volume: 112 start-page: 2735 issue: 17 year: 2005 ident: 324_CR11 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.105.169404 – volume: 350 start-page: S4 year: 1997 ident: 324_CR3 publication-title: Lancet doi: 10.1016/S0140-6736(97)90021-0 – volume: 3 start-page: 122 issue: 2 year: 2009 ident: 324_CR12 publication-title: J Cardiovasc Comput Tomogr doi: 10.1016/j.jcct.2009.01.001 – volume: 25 start-page: 1177 issue: 7 year: 2002 ident: 324_CR7 publication-title: Diabetes Care doi: 10.2337/diacare.25.7.1177 – volume: 25 start-page: 1135 issue: 7 year: 2002 ident: 324_CR5 publication-title: Diabetes Care doi: 10.2337/diacare.25.7.1135 – volume: 6 start-page: 11 year: 2014 ident: 324_CR28 publication-title: J Funct Foods doi: 10.1016/j.jff.2013.12.006 – volume: 39 start-page: 1345 issue: 11 year: 1996 ident: 324_CR6 publication-title: Diabetologia doi: 10.1007/s001250050581 – volume: 67 start-page: 665 issue: 7 year: 2013 ident: 324_CR22 publication-title: Int J Clin Pract doi: 10.1111/ijcp.12124 – volume: 30 start-page: 318 issue: 2 year: 2007 ident: 324_CR17 publication-title: Diabetes Care doi: 10.2337/dc06-0919 – volume: 39 start-page: 353 issue: 5 year: 2015 ident: 324_CR24 publication-title: Diab Metab J doi: 10.4093/dmj.2015.39.5.353 – volume: 28 start-page: 412 issue: 7 year: 1985 ident: 324_CR10 publication-title: Diabetologia doi: 10.1007/BF00280883 – volume: 2 start-page: 19 issue: 1 year: 2002 ident: 324_CR15 publication-title: Br J Diab Vasc Dis doi: 10.1177/14746514020020011301 – volume: 4 start-page: 191 issue: 2 year: 2011 ident: 324_CR13 publication-title: J Am Coll Cardiol Img doi: 10.1016/j.jcmg.2010.10.011 – volume: 23 start-page: 201 issue: 2 year: 2002 ident: 324_CR23 publication-title: Endocr Rev doi: 10.1210/edrv.23.2.0461 – volume: 50 start-page: S74 issue: Supplement year: 2009 ident: 324_CR26 publication-title: J Lipid Res doi: 10.1194/jlr.R800053-JLR200 – volume: 95 start-page: 3347 issue: 7 year: 2010 ident: 324_CR18 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2010-0288 – volume: 109 start-page: S516 issue: 4 year: 2000 ident: 324_CR27 publication-title: Exp Clin Endocrinol Diabetes doi: 10.1055/s-2001-15114 – volume: 5 start-page: e149 issue: 4 year: 2015 ident: 324_CR21 publication-title: Nutr Diab doi: 10.1038/nutd.2014.46 – volume: 24 start-page: 933 issue: 5 year: 2001 ident: 324_CR25 publication-title: Diabetes Care doi: 10.2337/diacare.24.5.933 – volume-title: Korean diabetes fact sheet 2015 [Internet] year: 2015 ident: 324_CR4 – volume: 44 start-page: S14 issue: 2 year: 2001 ident: 324_CR1 publication-title: Diabetologia doi: 10.1007/PL00002934 – reference: 18782902 - Diabetes Care. 2008 Nov;31(11):2154-9 – reference: 12087016 - Diabetes Care. 2002 Jul;25(7):1177-84 – reference: 25915739 - Nutr Diabetes. 2015 Apr 27;5:e149 – reference: 19272853 - J Cardiovasc Comput Tomogr. 2009 Mar-Apr;3(2):122-36 – reference: 11453039 - Exp Clin Endocrinol Diabetes. 2001;109(4):S516-26 – reference: 17531661 - J Am Coll Cardiol. 2007 May 29;49(21):2112-9 – reference: 11587045 - Diabetologia. 2001 Sep;44 Suppl 2:S14-21 – reference: 9250276 - Lancet. 1997 Jul;350 Suppl 1:SI4-9 – reference: 12087010 - Diabetes Care. 2002 Jul;25(7):1135-41 – reference: 26566492 - Diabetes Metab J. 2015 Oct;39(5):353-62 – reference: 11347757 - Diabetes Care. 2001 May;24(5):933-41 – reference: 21632070 - Metabolism. 2011 Dec;60(12):1673-6 – reference: 23758445 - Int J Clin Pract. 2013 Jul;67(7):665-72 – reference: 16085325 - Int J Cardiol. 2006 Mar 22;108(1):89-95 – reference: 19067533 - Metab Syndr Relat Disord. 2008 Dec;6(4):299-304 – reference: 3899825 - Diabetologia. 1985 Jul;28(7):412-9 – reference: 9096992 - Diabetes Care. 1997 Apr;20(4):627-31 – reference: 16157765 - Circulation. 2005 Oct 25;112(17):2735-52 – reference: 17259501 - Diabetes Care. 2007 Feb;30(2):318-24 – reference: 8933003 - Diabetologia. 1996 Nov;39(11):1345-50 – reference: 21665314 - Diabetes Res Clin Pract. 2011 Sep;93(3):e98-e100 – reference: 18997164 - J Lipid Res. 2009 Apr;50 Suppl:S74-9 – reference: 20484475 - J Clin Endocrinol Metab. 2010 Jul;95(7):3347-51 – reference: 21329905 - JACC Cardiovasc Imaging. 2011 Feb;4(2):191-202 – reference: 11943743 - Endocr Rev. 2002 Apr;23(2):201-29 – reference: 19336687 - Diabetes. 2009 Apr;58(4):773-95 |
| SSID | ssj0020766 |
| Score | 2.4882967 |
| Snippet | Background
Insulin resistance is one of the most important contributing factors to cardiovascular disease. This study aimed to investigate the association... Insulin resistance is one of the most important contributing factors to cardiovascular disease. This study aimed to investigate the association between... Background Insulin resistance is one of the most important contributing factors to cardiovascular disease. This study aimed to investigate the association... |
| SourceID | pubmedcentral proquest gale pubmed crossref springer |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 155 |
| SubjectTerms | Adult Aged Biomarkers - blood Biomedical and Life Sciences Blood Glucose Cardiovascular diseases Clinical Nutrition Complications and side effects Coronary Stenosis - blood Coronary Stenosis - pathology Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - pathology Fasting Female Humans Influence Insulin Resistance Life Sciences Lipidology Male Medical Biochemistry Middle Aged Risk Factors Triglycerides Triglycerides - blood Type 2 diabetes |
| SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1La9wwEBZpCqWX0iZ9uE3DFEoLbUxsWbKtU1lCQwikpwT2ZixLpoGsvV3vHvxD-n87I8ubeKG5-KIHY81oNDMafcPYZ7qpUrVNQ6sMD0VqUQ9KaUJlrdY6MlzVFO-4-pVe3IjLuZz7gFvn0ypHnegUtWkripGfkh1MddFV_mP5J6SqUXS76ktoPGFPHXQZynM2v3e40EdP_U1mnKenHZ5tgnIu0IdGOyLkk7NoVyM_OJJ20yV37kzdUXT-kr3wNiTMBqa_Ynu2OWCHswb950UPX8Bldbpw-QF7duUvzw_Z32v8nbu-QpkzFnyuOji4xBMoYUGJOitoa_D56YCeOFmXKBYncNtB6TlpDVD0FioCPyhXPbi00B5QXpoWR-B47NsvlkgO4cFCt9EU7emGYRT0BQ5j0Pc1uzn_eX12EfqqDGElk2wdZqVQaW6SJMlsjl8j48RWidayRnOsRAuO67zWVRKVMtUxN1Llsq4jYYzmuRXJG7bftI19xyBCfWJwslo4VP9S5UZllh631jIysQhYNPKnqDxkOVXOuCuc65KnxcDSgtLUiKUFD9i37ZDlgNfxWOevxPSC9jLOW5X-SQJSR6hYxUygtUivl2XAjiY9cQ9W0-ZRbAqvA7riXmID9mnbTCMpr62x7cb1cYA4GdLydpCyLdkcVT8uMk6eTeRv24GQwactze1vhxAu0fISWRaw76OkPiDrf6vx_vGf-MCec7d1VBjLI7a_Xm3sRzTI1vrY7bp_CCE0mg priority: 102 providerName: ProQuest – databaseName: SpringerLink Journals (ICM) dbid: U2A link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlR3LatwwUJQUSi-lTfpwkpYplBbamNqyZFvHpTSEQnrKQm7GsiQayHrDevfgD-n_ZkaWTby0hV580YwYPA_NSyPGPlClSjmbx1YZHovcoh2U0sTKWq11YrhylO-4_JlfLMWPa3kd7nF3Y7f7WJL0ltqrdZl_7fBkEtQxgREwegEx2t3HEkN30sYlX0xRFgbmeShf_hFtdgDtm-EH59B-j-ReodSfP-fP2bPgOMJi4PQL9si2h-xo0WLQvOrhI_hWTp8jP2RPLkPF_Ij9vsLw-7ZvUNCMhdCgDn5G4hnUsKLunA2sHYSmdMDwm1xKlIUzuOmgDuyzBihlCw1NPKg3Pfhe0B5QSNo1YiA-wvarOySHhsBCt9OU4ukGNMr0Aocx0_uSLc-_X327iMNTDHEjs2IbF7VQeWmyLCtsiV8j08w2mdbSoQ9Wo9vGdel0kyW1zHXKjVSldC4RxmheWpG9YgfturVvGCRoRAxu5oQf5V-r0qjC0o1WJxOTioglI3-qJswpp-cybisfr5R5NbC0ot40YmnFI_Z5QrkbhnT8C_gTMb0iBcZ9mzrcQ0DqaBRWtRDoItKVZRmx0xkkKl4zXx7FpgqK31UUrqHJTFUZsffTMmFSM1tr1zsP46fgFEjL60HKJrI52nv8ybh5MZO_CYDGgc9X2ptffiy4RHdLFEXEvoyS-oCsv_2N4_-CPmFPudckFafylB1sNzv7Fp2yrX7nlfAeFxcxKQ priority: 102 providerName: Springer Nature |
| Title | Triglyceride glucose index, a marker of insulin resistance, is associated with coronary artery stenosis in asymptomatic subjects with type 2 diabetes |
| URI | https://link.springer.com/article/10.1186/s12944-016-0324-2 https://www.ncbi.nlm.nih.gov/pubmed/27633375 https://www.proquest.com/docview/1826011198 https://www.proquest.com/docview/1820601672 https://pubmed.ncbi.nlm.nih.gov/PMC5024477 |
| Volume | 15 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlR1da9swUHQtjL2Mrd2Hty5oMDbY6s6RJct-GMMLLSWQMrYG8mYsS2aFxOniBOYfsv-7O1k2TegGe3EguhOHdLpvnQh5g5mqpDSRbxLNfB4ZkINCaD8xRikVaJaUGO-YXEYXUz6eidke6Z63cgtY3-na4XtS09X89NfP5jMc-E_2wMfRxxp0FsdaCvCNwT7wQSIfgGKK0Beb8D6pwMBlby8bycgHO2Pmkpx3TrGlpnaF9S1ttVtJuZNOtVrq_BF56MxLmrb88JjsmeqQHKUVuNaLhr6ltuDTRtIPyf2Jy6sfkd9X4KTPmwLYURvqytip7aR4QnO6wBqeFV2W1JWuU3DS0fAEjjmh1zXN3SYbTTGwSwvsi5CvGmorRhsKrFQtAQPwAbZZ3AA52CqW1huFgaC6RcN4MGW0iwc_IdPzs6vRhe8ebPALEcq1L3OeRLEOw1CaGL5aDENThEqJEiy1HIw7puJSFWGQi0gNmRZJLMoy4ForFhsePiX71bIyzwkNQNRomKzktuF_nsQ6kQbvvZYi0EPukaDbn6xw3czxUY15Zr2aOMraLc2wgg23NGMeed-j3LStPP4F_A43PUPGg3mL3N1WAOqwYVaWcjAk8WKz8MjxFiQcz2J7uGObrOPuDJ06EKzDJPbI634YMbHkrTLLjYWxvXIk0PKs5bKebAZaARYZJpdb_NcDYNPw7ZHq-odtHi7AKONSeuRDx6m3yPrbarz4n6V7SR6AVcnaisdjsr9ebcwrsNzWakDuyZkckIM0HX8fw--Xs8uv3-DfUTQa2GjIwJ5Y-E5Z-gdcNEPj |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3bbtMw9Gh0EvCCYONSGGAkLhIsWurYuTwgVGBTx9YKoU3aW4hjR0xa09K0QvkQfoNv5BzHKWsl9raXvPgix-d-fC4AL-mlKilM6JlEc0-EBvmglNpLjFFK-ZonBfk7hqNwcCq-nMmzDfjT5sJQWGXLEy2j1pOcfOR7pAdTX_Qk_jD96VHXKHpdbVtoNGhxZOpfaLJV7w8_I3xfcX6wf_Jp4LmuAl4ug2juRZlIwlgHQRCZGL9a9gKTB0rJAtWJDDUQruJC5YGfyVD1uJZJLIvCF1orHhsR4L43YFNQRmsHNj_uj75-W5p4fhSG7u20F4d7FUpTQVEeaLWj5uLxFem3LgMuCcH1AM21V1or_A7uwh2ntbJ-g2b3YMOUW7DdL9FiH9fsNbNxpNZBvwU3h-65fht-n-AFXtQ5Yrk2zEXHM1ugcZdlbEyhQTM2KZiLiGdo-5M-i4i4y84rljncMZqRv5jlVG4hm9XMBqLWDDG0nOAKXI9z6_EUj0MVaFm1UORfqppl5GZmnLVu5vtwei0QewCdclKaR8B85GAaNyuE7SOQJbFOIkPptIX0dU90wW_hk-auSDr16rhIrbEUh2kD0pQC4wikKe_C2-WSaVMh5KrJbwjoKXEP3DfPXBIEno7qcKV9gfop5UvLLuyszESqz1eHW7RJHdep0n800oUXy2FaSZF0pZks7BxbgifCszxssGx5bI7CBi8ZN49W8G85gWqRr46U5z9sTXKJup6Ioi68azH10rH-dxuPr_6J53BrcDI8To8PR0dP4Da3ZJR4PbkDnflsYZ6iOjhXzxwNMvh-3WT_F6alclM |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1La9wwEBYlhdBLaZI-3KbtFEoLbUz8kGzruKRd0kdCDwnkZixLIoGsd1nvHvxD-n8zI8smu7SFXnzRjBCe0Whe-sTYe6pUSWuy0EidhDwzaAeF0KE0RikV6URaynecnWenl_z7lbjy75y2Q7f7UJLs7zQQSlOzOl5o22_xIjtu8ZTi1D2B0TB6BCHa4IecTj6q1mYnY8SFQXrmS5l_ZNs4jLZN8r0zabtfcqto6s6i6RP22DuRMOmlvscemGafHUwaDKBnHXwA19bp8uX7bPfMV88P2O8LDMVvuxqVThvwzerg8BKPoIIZdeosYW7BN6gDhuLkXqJeHMFNC5UXpdFA6VuoCf2gWnbg-kI7QIVp5siB_EjbzRa4HAKEhXatKN3T9myU9YUEhqzvU3Y5_Xpxchr6ZxnCWqT5KswrLrNCp2mamwK_WsSpqVOlhEV_rEIXLlGFVXUaVSJTcaKFLIS1EddaJYXh6TO208wb84JBhAZF42SWO1j_ShZa5oZut1oR6ZgHLBrkU9Yes5yezrgtXexSZGUv0pL61EikZRKwTyPLogfs-BfxRxJ6SZsZ560rfycBV0ewWOWEo7tI15dFwA43KHET1pvDg9qU3gi0JYVuaD5jWQTs3ThMnNTY1pj52tE4RJwc1_K817Jx2QnafvzJOHm-oX8jAUGDb440N9cOIlyg68XzPGCfB029t6y__Y2X_0X9lu3--jItf347__GKPUrcppJhLA7Zzmq5Nq_RV1upN24_3gGMvDhC |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Triglyceride+glucose+index%2C+a+marker+of+insulin+resistance%2C+is+associated+with+coronary+artery+stenosis+in+asymptomatic+subjects+with+type+2+diabetes&rft.jtitle=Lipids+in+health+and+disease&rft.au=Lee%2C+Eun+Young&rft.au=Yang%2C+Hae+Kyung&rft.au=Lee%2C+Joonyub&rft.au=Kang%2C+Borami&rft.date=2016-09-15&rft.issn=1476-511X&rft.eissn=1476-511X&rft.volume=15&rft.issue=1&rft_id=info:doi/10.1186%2Fs12944-016-0324-2&rft.externalDBID=n%2Fa&rft.externalDocID=10_1186_s12944_016_0324_2 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1476-511X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1476-511X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1476-511X&client=summon |